[Biopython] Support for Xdna, SnapGene and GCK formats

Peter Cock p.j.a.cock at googlemail.com
Tue Aug 6 18:46:52 UTC 2019


Damien's pull request is here:

https://github.com/biopython/biopython/pull/2204

Peter

On Thu, Aug 1, 2019 at 1:29 PM Peter Cock <p.j.a.cock at googlemail.com> wrote:
>
> On Thu, Aug 1, 2019 at 1:19 PM Damien Goutte-Gattat
> <dgouttegattat at incenp.org> wrote:
> >
> > On Thu, Aug 01, 2019 at 10:01:22AM +0100, Peter Cock wrote:
> > >> All the GCK files I have come from the "Drosophila Gateway Vector
> > >> Collection" [1]; those files are not explicitly released under any free
> > >> license (in fact there are no license terms at all), so I don't think we
> > >> could bundle even one of them with the Biopython's source code, even if
> > >> it is just to serve as a test file.
> > >
> > >The website [1] had a fairly liberal copyright statement at the bottom,
> > >suggesting a sample file could be used with attribution (e.g. in the git
> > >check in comment and where the test or example code used it)?
> >
> > The notice states "You are free to use the information contained on this
> > page for non-profit purpose [...]". I am not sure this would be
> > compatible with either the 3-clause BSD license or the Biopython License
> > Agreement (neither of them excluding any kind of for-profit use).
> >
> > I am also slightly concerned by the following statement: "Portions of
> > the material contained in the Drosophila Gateway Vector collection are
> > subject to international patents [...]". I guess this refers to the
> > vectors themselves and not merely to files containing their sequences,
> > but I wonder if that could be subject to interpretation.
> >
> > Obviously I am no lawyer, so maybe I am just worrying too much. :)
>
> Sadly I think you are right. I was thinking just about the immediate (and
> to me clearly non-profit) step of validating Biopython functionality - there
> is definitely a problem in redistribution to anyone using Biopython in a
> for-profit setting, unless one sample file is judged fair use (and that is
> a legal grey area).
>
> > >Damien, you evidently know a lot more about email headers etc than me.
> > >Are you also familiar with mailman, and how it might be better configured
> > >on this specific point?
> >
> > Yes.
> >
> > Basically there's two options.
> >
> > ...
> >
> > Unfortunately, `from_is_list` has been introduced in Mailman 2.1.16 and
> > `dmarc_moderation_action` in Mailman 2.1.18, but mailman.open-bio.org is
> > running Mailman 2.1.15, so an upgrade would be needed before we can
> > adopt that approach.
>
> That seems worth looking at - I will forward this to the OBF mailman team.
>
> Thank you,
>
> Peter


More information about the Biopython mailing list